Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Amgen Inc.
Current Parent Company: Amgen
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Penalty: $71,000,000
Year: 2015
Date: August 18, 2015
Offense Group: healthcare-related offenses
Primary Offense: off-label or unapproved promotion of medical products
Mega-Scandal: Improper Drug Marketing
Violation Description: Amgen agreed to pay $71 million to settle multistate litigation alleging that it unlawfully promoted its biologic medications Aranesp and Enbrel for unapproved uses.
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
HQ Country of Current Parent: USA
HQ State of Current Parent: California
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.